Procyon Corporation (PCYN)

Market Cap	2.05M +124.7%
Revenue (ttm)	4.98M +6.4%
Net Income	-312.96K
EPS	-0.04
Shares Out	8.19M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,000
Open	0.2500
Previous Close	n/a
Day's Range	0.2500 - 0.2500
52-Week Range	0.1000 - 0.2800
Beta	61,790.54
Analysts	n/a
Price Target	n/a
Earnings Date	May 29, 2026

About Procyon

Procyon Corporation, together with its subsidiaries, manufactures and markets wound and skin care products primarily in the United States. It provides AMERIGEL, an advanced skin and wound care products, including hydrogel wound dressing, post op surgical kits, saline wound washes, and care and barrier lotions; HELIX3 Bioactive Collagen products, such as collagen powder, gel, and matrix; and calcium alginate dressing, foam dressing, amerx gauze dressing, hyrdocolloid dressing, as well as wound care kits, including calcium alginate, collagen matr...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1987
• Employees: 20
• Stock Exchange: OTCMKTS
• Ticker Symbol: PCYN

Financial Performance

In fiscal year 2024, Procyon's revenue was $4.98 million, an increase of 6.35% compared to the previous year's $4.69 million. Losses were -$312,962, 367.4% more than in 2023.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Aug 18, 2026

Data Sources Report a data error